(株)カイオム・バイオサイエンスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4583/E26096 | Chiome Bioscience Inc. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2013/01/18 | 日証協 | 240,900株 | -21.86% | 1,000株 | -99.57% | 156,804株 | -36.47% | 3,000株 | -77.78% |
2013/01/11 | 日証協 | 308,300株 | +57.06% | 234,200株 | +187.36% | 246,806株 | +58.08% | 13,502株 | +7.83% |
2013/01/04 | 日証協 | 196,300株 | +127.46% | 81,500株 | -64.39% | 156,124株 | +86.74% | 12,522株 | -94.75% |
2012/12/28 | 日証協 | 86,300株 | +3.11% | 228,900株 | +638.39% | 83,604株 | +6.23% | 238,325株 | +1626.99% |
2012/12/21 | 日証協 | 83,700株 | -34.91% | 31,000株 | +811.76% | 78,704株 | -43.22% | 13,800株 | +105.97% |
2012/12/14 | 日証協 | 128,600株 | -24.49% | 3,400株 | +9.68% | 138,604株 | -34.87% | 6,700株 | -52.48% |
2012/12/07 | 日証協 | 170,300株 | -3.46% | 3,100株 | -60.76% | 212,804株 | +1.24% | 14,100株 | -80.47% |
2012/11/30 | 日証協 | 176,400株 | +2.2% | 7,900株 | -81.1% | 210,204株 | +2.64% | 72,200株 | +116.82% |
2012/11/22 | 日証協 | 172,600株 | +0.12% | 41,800株 | +543.08% | 204,804株 | -0.53% | 33,300株 | -30.33% |
2012/11/16 | 日証協 | 172,400株 | -13.76% | 6,500株 | -97.19% | 205,904株 | -20.87% | 47,800株 | -65.19% |
2012/11/09 | 日証協 | 199,900株 | +851.9% | 231,400株 | +52.74% | 260,204株 | +169.91% | 137,300株 | +4.57% |
2012/11/02 | 日証協 | 21,000株 | +118.75% | 151,500株 | +9368.75% | 96,404株 | +14.49% | 131,300株 | +5147.8% |
2012/10/26 | 日証協 | 9,600株 | -67.57% | 1,600株 | -11.11% | 84,204株 | -18.72% | 2,502株 | -16.6% |
2012/10/19 | 日証協 | 29,600株 | -85.97% | 1,800株 | +125% | 103,602株 | -62.15% | 3,000株 | -14.29% |
2012/10/12 | 日証協 | 211,000株 | +0.33% | 800株 | -50% | 273,702株 | +0.37% | 3,500株 | -85.94% |
2012/10/05 | 日証協 | 210,300株 | -10.78% | 1,600株 | 0% | 272,702株 | -0.73% | 24,900株 | -58.29% |
2012/09/28 | 日証協 | 235,700株 | 0% | 0株 | -100% | 274,720株 | +0.11% | 59,702株 | +1958.69% |
2012/09/21 | 日証協 | 235,700株 | -0.97% | 20,400株 | +19.3% | 274,422株 | -1.4% | 2,900株 | +107.14% |
2012/09/14 | 日証協 | 238,000株 | +14.26% | 17,100株 | -67.24% | 278,322株 | +12.22% | 1,400株 | -97.62% |
※株式分割は考慮していませんのでご注意ください。
Page Top